Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

NEUROSTIMULATION - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the Global markets for Neurostimulation in US$ Million by the following Product Segments: Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable Pulse Generator (IPG)}, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS). The US market is analyzed both in terms of value (US$) and Volume (Units) for all the above listed Product Segments, and also additionally for Gastric Electric Stimulators (GES). The report provides separate comprehensive analytics for the United States, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 21 companies including many key and niche players such as Boston Scientific Corp., Cyberonics, Inc., Medtronic, Inc., St. Jude Medical, Inc., Synapse Biomedical, Inc., and SPR Therapeutics, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Code : MCP-1227
Price : $4950
Companies : 21
Pages : 228
Date : October, 2012
Market Data Tables : 82

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  NEUROSTIMULATION (Complete Report) Pages : 228   | $4950
 
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS  
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Spinal Cord Stimulation (SCS).....I-3
  
   Radio Frequency (RF) Systems.....I-4
Implantable Pulse Generator Systems (IPGs).....I-4
Deep Brain Stimulation (DBS).....I-4
Sacral Nerve Stimulation (SNS).....I-4
Vagus Nerve Stimulation (VNS).....I-4
  
II. EXECUTIVE SUMMARY72$2650
  1. MARKET SNAPSHOTS.....II-11 $100  
   Market Snapshots.....II-11$100
  2. MARKET OVERVIEW.....II-26 $595  
   Rising Demand for Neurostimulation Devices.....II-21$100
   Current and Future Analysis.....II-3 1$100
   Table 1: Worldwide Neurostimulation Market (2010-2018): Product Segments (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, and Vagus Nerve Stimulators) Ranked by Growth (includes corresponding Graph/Chart).....II-41$350
   Neurostimulation Therapy Gets Popular.....II-5
Technological Advancements So Far.....II-5
SCS - The New Painkiller.....II-5
Future Prospects.....II-5
1$100
   Obesity Control to Spur Market Growth in Future.....II-61$100
   Major Neurostimulation Therapies And Indications At A Glance.....II-71$100
  3. TRENDS AND ISSUES.....II-84 $395  
   Chip Makers Struggle to Meet Quality Demand.....II-8
Market Growth Attracts New Investors.....II-8
Neurostimulation on a Rise with Growing Indications.....II-8
Neurostimulation Market Marked by High Entry Barriers.....II-8
1$100
   Increasing Acceptance of Neurostimulation due to Advanced Clinical Benefits.....II-9
Powering Neurostimulation Devices-The Key to Success.....II-9
Market Development Initiatives to Fuel Market Growth.....II-9
1$100
   Exploring Market Opportunities – The Technology Way.....II-10
Neurostimulation Devices – Growing Awareness and Acceptance Among Physicians.....II-10
Synergy with Pharma & Biotech Companies Creates New Avenues.....II-10
1$100
   Third-Party Reimbursement – A Vital Role to Play.....II-111$100
  4. COMPETITIVE SCENARIO.....II-124 $495  
   Few Players Dominate Neurostimulation Market.....II-12
Worldwide Neurostimulation Market: Leading Players by Product Segment.....II-12
1$100
   Table 2: Leading Players in the Global Neurostimulation Market (2011): Percentage Share Breakdown of Value Sales for Medtronic, St. Jude Medical, Boston Scientific, Cyberonics and Others (includes corresponding Graph/Chart).....II-13

Table 3: World Neurostimulation Market (2012): Percentage Share Breakdown of Value Sales for Pain, Deafness, Epilepsy, Movement Disorders, Depression, Stroke, Incontinence, Gastroparesis and Obesity (includes corresponding Graph/Chart).....II-13
1$350
   Product Offerings of Leading Players in the Neurostimulation Market.....II-14
Select Spinal Cord Stimulation Product Offerings of St. Jude and Medtronic.....II-14
1$100
   Stimulation Parameters of Select SCS Products.....II-15
Companies Researching Neurostimulator Applications by Indication.....II-15
1$100
  5. EMERGING THERAPIES IN NEURO STIMULATION.....II-162 $200  
   ElectroCore to Demonstrate GammaCore at EHMTIC 2012.....II-16
University of Alabama Develops DBS Therapy for Parkinson’s Disease.....II-16
California Based Medical Center Innovates Brain-controlled Prosthetic Limb.....II-16
1$100
   Toronto Western Hospital Develops DBS Therapy for Alzheimers Disease.....II-17
SPR Therapeutics Successfully Demonstrates PNS Therapy in Stroke Victim.....II-17
1$100
  6. NEUROMODULATION INDUSTRY: AN INSIGHT.....II-182 $200  
   Attacking the Source of Pain - The Logic behind Neuromodulation.....II-18
Growth Prospects for Neuromodulation Industry.....II-18
2$200
  7. PRODUCT OVERVIEW.....II-209 $595  
   Introduction to Neurostimulator.....II-20
A Historical Note.....II-20
Neurostimulation Devices by Product Segment.....II-20
1$100
   Spinal Cord Stimulation (SCS).....II-211$100
   SCS – What it Treats .....II-22
Segmentation by Type of Power Source.....II-22
Implantable Pulse Generator Systems (IPGs).....II-22
Radio Frequency (RF) Systems.....II-22
1$100
   Market Assessment for RF Systems.....II-23
Sacral Nerve Stimulation (SNS).....II-23
1$100
   Deep Brain Stimulation (DBS).....II-24
Vagus Nerve Stimulation (VNS).....II-24
1$100
   Gastric Electric Stimulation (GES).....II-25
Stimulation Device – How it Works .....II-25
Neurostimulation & its Benefits.....II-25
1$100
   Prospective Application Areas for Neurostimulators – Select Indications.....II-261$100
   Neurostimulation Indications and Use of Related Devices/Techniques in the US.....II-27
Approved Indications for Spinal Cord Stimulation by Geographic Regions.....II-27
Neurostimulation Devices – Technology & Safety Issues.....II-27
2$200
  8. NEUROSTIMULATION DEVICE APPROVALS.....II-298 $495  
   SPR™ Therapeutics’ SMARTPATCH™ Neurostimulation System Obtains FDA’s IDE
  Approval.....II-29
Bioness Receives FDA Clearance for Use of Smaller Leg Cuff with L300 Foot Drop
  System.....II-29
Imthera Medical’s AURA6000 Awarded CE Mark for Sleep Apnea Therapy.....II-29
1$100
   Neuronetics’ Magnetic Brain Stimulation Device Receives CE Approval.....II-30
St. Jude Medical’s Eon Mini Stimulator Obtains European CE Mark Approval.....II-30
Boston Scientific’s Precision Plus SCS Wins FDA Approval for Limb Pain.....II-30
Boston Scientific’s Infinion™ 16 Percutaneous Lead Obtains CE Approval.....II-30
1$100
   NeuroSigma Obtains CE Approval for Monarch Nerve Stimulation System.....II-31
Neurotech’s ADNS-300 Neurostimulation Device Obtains CE Mark Approval.....II-31
Bioness Bags FDA Approval for NESS L300 Plus, for Managing Thigh Weakness.....II-31
Bioness Obtains CE Mark Approval and FDA Clearance For NESS H200 Hand Rehabilitation
  System.....II-31
1$100
   Boston Scientific’s Clik Anchor Obtains FDA Approval.....II-32
Medtronic’s AdaptiveStim RestoreSensor Lands US FDA Approval.....II-32
Synapse Biomedical Obtains FDA Approval for NeuRx Diaphragm Pacing System.....II-32
St Jude Medical's Genesis System Secures CE Mark Approval.....II-32
1$100
   St. Jude Receives Approval for Neurostimulation System from Japanese MHLW.....II-33
St. Jude Secures European CE Mark Approval for Epiducer™ Lead Delivery System.....II-33
St. Jude Medical Obtains TGA Approval for Brio™ DBS System.....II-33
Boston Scientific Secures FDA Approval for D4 and W4 SCS Lead Splitters.....II-33
1$100
   St. Jude Medical Receives Approval for Penta Neurostimulation Lead from FDA.....II-34
St. Jude Receives European CE Mark Approval for LibraXP™ and Libra® Deep Brain
  Stimulation Systems.....II-34
Medtronic Receives FDA Approval for Activa PC and Activa RC DBS Devices.....II-34
Medtronic Receives FDA Approval for Reclaim™ Deep Brain Stimulation Therapy.....II-34
1$100
   St. Jude Receives European CE Mark Approval for Genesis® Neurostimulation
  System.....II-35
St. Jude Eon Mini™ Neurostimulator Receives Australian Therapeutic Goods Administration
  Approval.....II-35
Medtronic Receives FDA Approval for Activa® RC, Activa PC DBS Devices.....II-35
2$200
  9. RECENT INDUSTRY ACTIVITY.....II-375 $395  
   Cyberonics Collaborates with Imricor Medical for Developing MRI Compatible
  Leads.....II-37
Boston Scientific Takes Over Intelect Medical.....II-37
GE Healthcare Inks Distribution and Marketing Agreement with KC BioMedix.....II-37
1$100
   Cyberonics and ImThera to Develop Neurostimulation Technology for OSA.....II-38
NDI Medical Establishes New Business Unit for Advancement of IPG Technology.....II-38
Sonova Holding Acquires Advanced Bionics.....II-38
Medtronic Initiates Clinical Trial for RestoreSensor.....II-38
1$100
   NeuroMetrix Purchases Select Assets of Cyberkinetics Neurotechnology Systems.....II-39
St. Jude Medical Purchases Non-Cash Assets and Intellectual Property of Northstar
  Neuroscience.....II-39
Victhom Human Bionics Signs Agreement with Otto Bock HealthCare.....II-39
1$100
   Neuros Medical Collaborates with Battelle.....II-40
JumpStart & CTV Invest in Neuros Medical.....II-40
InterWest Invests in Autonomic Technologies.....II-40
1$100
   MicroTransponder Finalizes Series A Funding Round for Wireless Neurostimulator
  Development.....II-41
1$100
  10. PRODUCT INNOVATIONS/INTRODUCTIONS.....II-424 $395  
   Bioness Launches L300 Plus Foot Drop System in the US For Patients with Gait
  Disorders.....II-42
St.Jude Medical Launches Penta Surgical Leads in Japan.....II-42
Neurotech® Introduces Kneehab® XP Quadriceps Therapy System.....II-42
1$100
   St.Jude Medical Launches Epiducer Lead Delivery System in Australia.....II-43
Neurowave Medical Technologies™ Unveils Reletex™ Neuromodulation Device.....II-43
ST Jude Medical Rolls out Genesis Neurostimulation System in Japan.....II-43
1$100
   Medtronic Unveils Brain Stimulation Products.....II-44
Alphalife Launches Alpha Brainwave Neurostimulator.....II-44
ImThera Medical Introduces aura6000™ Neurostimulation System.....II-44
Mobilis Healthcare Introduces InterX.....II-44
1$100
   IMEC Develops and Models New Design for Brain Stimulation Implants.....II-451$100
  11. FOCUS ON SELECT PLAYERS.....II-463 $295  
   Bioness Inc. (USA).....II-46
Boston Scientific Corp. (USA).....II-46
Cyberonics, Inc. (USA).....II-46
1$100
   Medtronic, Inc. (USA).....II-47
St. Jude Medical, Inc. (USA).....II-47
1$100
   Synapse Biomedical, Inc. (USA).....II-48
SPR Therapeutics, LLC (US).....II-48
1$100
  12. GLOBAL MARKET PERSPECTIVE.....II-49   
   Table 4: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-491$350
   Table 5: World Historic Review for Neurostimulation by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-501$350
   Table 6: World 15-Year Perspective for Neurostimulation by Geographic Region – Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-511$350
   Table 7: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-521$350
   Table 8: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-531$350
   Table 9: World Historic Review for Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-541$350
   Table 10: World Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-551$350
   Table 11: World 15-Year Perspective for Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-561$350
   Table 12: World 15-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-571$350
   Table 13: World Recent Past, Current & Future Analysis for Radio Frequency Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-581$350
   Table 14: World Historic Review for Radio Frequency Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-591$350
   Table 15: World 15-Year Perspective for Radio Frequency Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-601$350
   Table 16: World Recent Past, Current & Future Analysis for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-611$350
   Table 17: World Historic Review for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-621$350
   Table 18: World 15-Year Perspective for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-631$350
   Table 19: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-641$350
   Table 20: World Historic Review for Deep Brain Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-651$350
   Table 21: World 15-Year Perspective for Deep Brain Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-661$350
   Table 22: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-671$350
   Table 23: World Historic Review for Sacral Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-681$350
   Table 24: World 15-Year Perspective for Sacral Nerve Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-691$350
   Table 25: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-701$350
   Table 26: World Historic Review for Vagus Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2004 through 2009 (includes corresponding Graph/Chart).....II-711$350
   Table 27: World 15-Year Perspective for Vagus Nerve Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....II-721$350
III. MARKET45$2350
  1. THE UNITED STATES.....III-133 $1995  
   A. Market Analysis.....III-1
Overview.....III-1
Neurostimulation Products Market to Witness Growth.....III-1
1$75
   Product Segments Ranked by Growth.....III-2
Table 28: Neurostimulation Market in the US (2010-2018): Product Segments Ranked by Growth (Sales in US$ million)(includes corresponding Graph/Chart).....III-2
1$200
   Table 29: Neurostimulation Market in the US (2010-2018): Product Segments Ranked by Growth (Sales in Units) (includes corresponding Graph/Chart).....III-3

Table 30: Neurostimulation Market in the US (2011): Unit Sales & Percentage Breakdown by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart).....III-3
1$200
   Table 31: Neurostimulation Market in the US (2011): Value Sales (in US$ Million) & Percentage Market Share by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart).....III-4
Potential Growth for Neurostimulation Systems in the US.....III-4
1$200
   Spinal Cord Stimulation Products Market.....III-5
Table 32: US Spinal Cord Stimulator Market (2011): Percentage Share Breakdown by Company – Medtronic, St.Jude Medical Boston Scientific (includes corresponding Graph/Chart).....III-5
Sacral Nerve Stimulation Products Market.....III-5
1$200
   Deep Brain Stimulation Products Market.....III-6
Shift Away from Orthopaedic and Cardiovascular Device Markets.....III-6
1$75
   Trends in the Embolotherapy Market.....III-71$75
   Neurovascular Stents Market Attracting Cardiovascular Companies.....III-8
Migraine Devices – New Frontiers for Neurostimulation.....III-8
Competitive Landscape.....III-8
1$75
   Table 33: Leading Players in the US Neurostimulation Market (2011): Percentage Breakdown of Revenues for Medtronic, Advanced Bionics, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart).....III-9
Neurostimulation Device Approvals.....III-9
4$800
   Recent Industry Activity.....III-134$300
   Product Innovations/ Introductions.....III-172$150
   Key Players.....III-193$225
   B. Market Analytics.....III-22
Table 34: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-22
1$200
   Table 35: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-231$200
   Table 36: US Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-241$200
   Table 37: US Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-251$200
   Table 38: US 15-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-261$200
   Table 39: US 15-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-271$200
   Table 40: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-281$200
   Table 41: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-291$200
   Table 42: US Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-301$200
   Table 43: US Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-311$200
   Table 44: US 15-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Unit Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-321$200
   Table 45: US 15-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-331$200
  2. REST OF WORLD.....III-3412 $1450  
   A. Market Analysis.....III-34
Outlook.....III-34
Neurostimulation Device Approvals.....III-34
4$300
   Recent Industry Activity.....III-38
Product Innovations/ Introductions.....III-38
2$150
   B. Market Analytics.....III-40
Table 46: Rest of World Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-40
1$200
   Table 47: Rest of World Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-411$200
   Table 48: Rest of World 15-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-421$200
   Table 49: Rest of World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-431$200
   Table 50: Rest of World Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-441$200
   Table 51: Rest of World 15-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2004, 2011 and 2018 (includes corresponding Graph/Chart).....III-451$200
IV. COMPETITIVE LANDSCAPE 98$995
  
Total Companies Profiled: 21 (including Divisions/Subsidiaries - 24)

Region/Country                 Players

The United States                 16    
Canada                             1
Europe                             5
     The United Kingdom            2
     Rest of Europe                3
Asia-Pacific (Excluding Japan)     1
Middle-East                        1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign